A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00825149 · COMPLETED
Trial details
- NCT number
- NCT00825149
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.